Medicare Group QSC

As of June 30, 2026, Medicare Group QSC carries a market capitalization of 1.59B, placing it among publicly traded companies globally. Its enterprise value stands at 1.68B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Medicare Group QSC's next confirmed earnings release is scheduled for October 27, 2026.

As of June 30, 2026, Medicare Group QSC has 281.44M shares outstanding.

As of June 30, 2026, Medicare Group QSC trades at a trailing price-to-earnings ratio of 18.74. The price-to-sales ratio is 3.19, and the price-to-book ratio stands at 1.57.

As of June 30, 2026, Medicare Group QSC trades at an EV/EBITDA multiple of 17.80 - the valuation measure that neutralizes differences in capital structure, tax rates, and depreciation policy, making it the standard yardstick for comparing companies across an industry. The EV/Sales ratio of 3.38 reflects the premium investors pay for the company's revenue stream, a useful check when earnings are depressed or negative. Its EV/EBIT multiple of 22.23 values the business against core operating earnings after depreciation, a stricter test than EV/EBITDA for capital-intensive businesses. Medicare Group QSC trades at an EV/FCF ratio of 16.90, comparing the total takeover cost of the business to the cash it actually generates for all capital providers. These enterprise value multiples are built on an enterprise value of 1.68B versus a market cap of 1.59B, with the gap driven by net debt and cash on the balance sheet.

As of June 30, 2026, Medicare Group QSC maintains a current ratio of 1.09, meaning it holds 1.1x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 13.35, indicating elevated leverage, while an interest coverage ratio of 686.98 demonstrates strong ability to service its debt obligations.

Over the twelve months ended June 30, 2026, Medicare Group QSC posted a return on equity (ROE) of 8.29, showing how much profit the company earns on every dollar of shareholder capital. Return on invested capital (ROIC) comes in at 6.75 - the clearest signal of whether the business earns more on its capital than that capital costs, and the core measure of a durable competitive advantage. Return on assets (ROA) stands at 6.10, measuring how efficiently the asset base is converted into earnings. Return on capital employed (ROCE) is 7.20, useful for judging operating efficiency across full business cycles. Inventory turnover of 11.22 indicates how many times Medicare Group QSC sells and replaces its inventory over a year, a key working capital efficiency ratio.

As of the close on October 22, 2026, Medicare Group QSC's stock has declined approximately 27.18% over the past 52 weeks. The 50-day moving average sits at 5.20, while the 200-day moving average is 5.63.

Over the twelve months ended June 30, 2026, Medicare Group QSC generated 496.77M in revenue and converted that into 84.66M in net income, yielding earnings per share of 0.30. EBITDA reached 94.39M, while operating income came in at 40.19M.

As of June 30, 2026, Medicare Group QSC holds 47.06M in cash and equivalents against 135.71M in total debt, resulting in a net debt position of 88.65M. Total book value stands at 1.02B, with working capital of 13.94M providing operational flexibility.

Medicare Group QSC produced 133.28M in operating cash flow over the twelve months ended June 30, 2026. After subtracting -34.02M in capital expenditures, free cash flow totaled 99.26M - equivalent to 0.35 per share.

Over the twelve months ended June 30, 2026, Medicare Group QSC posted a gross margin of 31.79, reflecting its pricing power and cost economics. The operating margin of 8.09 and net profit margin of 17.04 provide insight into operational efficiency.

Over the twelve months ended June 30, 2026, Medicare Group QSC paid dividends of 0.20 per share. The dividend payout ratio of 65.86 indicates the proportion of earnings distributed to shareholders, a key gauge of how sustainable the dividend is and how much room remains for future dividend growth. Free cash flow yield stands at 6.26, showing how much cash the business generates relative to its market value - dividends covered by free cash flow are generally more durable than those funded by debt. Total shareholder yield reaches 9.44, combining dividends paid with share buybacks and debt reduction for a fuller picture of capital returned to Medicare Group QSC shareholders.

Medicare Group QSC's most recent stock split took place on June 20, 2019 with a 1:10 split ratio.

As of June 30, 2026, Medicare Group QSC has an Altman Z-Score of 3.32, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.